Secondly, the protein expression data obtained in vitro contrast those obtained ex vivo, probably because SIRT-3 and its downstream effectors have been investigated in patients undergoing chronic treatment with metformin for the presence of T2DM, which represents a complex clinical condition not reproducible in cell lines. Here, SIRT3 is linked to type 2 diabetes mellitus.